FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function

Blood

Volumn 98, Issue 9, 2001, Pages 2707-2713

  Lean, Jeny Maree ^a   Fuller, Karen ^a   Chambers, Timothy John ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLONY STIMULATING FACTOR 1; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; STEM CELL FACTOR; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; HEMATOPOIESIS; INJECTION; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035525765     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.9.2707     Document Type: Article

References (55)

1. Athanasou NA. Current concepts review: cellular biology of bone-resorbing cells. J Bone Joint Surg Am. 1996;78:1096-1112.
2. Helfrich MH, Horton MA. Antigens of osteoclasts: phenotypic definition of a specialized hemopoietic cell lineage. In: Horton MA, ed. Blood Cell Biochemistry: Macrophages and Related Cells. Vol 5. New York, NY: Plenum Press; 1993:183-202.
3. Chambers TJ. The origin of the osteoclast. In: Peck W, ed. Bone and Mineral Research Annual. Vol 6. Amsterdam: Elsevier; 1989:1-25.
4. Chambers TJ, Revell PA, Fuller K, Athanasou NA. Resorption of bone by isolated rabbit osteoclasts. J Cell Sci. 1984;66:383-399.
5. Chambers TJ, Horton MA. Failure of cells of the mononuclear phagocyte series to resorb bone. Calcif Tissue Int. 1984;36:556-558.
6. Fuller K, Chambers TJ. Effect of arachidonic acid metabolites on bone resorption by isolated rat osteoclasts. J Bone Miner Res. 1989;4:209-215.
7. Wong BR, Josien R, Lee SY, et al. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med. 1997;186:2075-2080.
8. Wong BR, Rho J, Arron J, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem. 1997;272:25190-25194.
9. Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 1997;390:175-179.
10. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med. 1998;188:997-1001.
11. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165-176.
12. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE-RANKL. Proc Natl Acad Sci U S A. 1998;95:3597-3602.
13. Jimi E, Akiyama S, Tsurukai T, et al. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol. 1999;163:434-442.
14. Hsu H, Lacey DL, Dunstan CR, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A. 1999;96:3540-3545.
15. Kong Y-Y, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999;397:315-323.
16. Chambers TJ. Regulation of osteoclast development and function. In: Rifkin BR, Gay CV, eds. Biology and Physiology of the Osteoclast. Boca Raton: CRC Press; 1992:105-128.
17. btsA58 transgenic mouse. Proc Natl Acad Sci U S A. 1993;90:5578-5582.
18. 2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion. Endocrinology. 1999;140:1927-1935.
19. Arai F, Miyamoto T, Ohneda O, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J Exp Med. 1999;190:1741-1754.
20. Yoshida H, Hayashi S-I, Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 1990;345:442-444.
21. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A. 1990;87:4828-4832.
22. Marks SC, Lane PW. Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J Hered. 1976;67:11-18.
23. Myint YY, Miyakawa K, Naito M, et al. Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation. Am J Pathol. 1999;154:553-566.
24. Wiktor-Jedrzejczak W, Urbanowska E, Szperl M. Granulocyte-macrophage colony-stimulating factor corrects macrophage deficiencies, but not osteopetrosis, in the colony-stimulating factor-1-deficient op/op mouse. Endocrinology. 1994;134:1932-1935.
25. Hattersley G, Chambers TJ. Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue. J Cell Physiol. 1990;142:201-209.
26. Takahashi N, Udagawa N, Akatsu T, et al. Role of colony-stimulating factors in osteoclast development. J Bone Miner Res. 1991;6:977-985.
27. Shinar DM, Sato M, Rodan GA. The effect of hemopoietic growth factors on the generation of osteoclast-like cells in mouse bone marrow cultures. Endocrinology. 1990;126:1728-1735.
28. Shuto T, Kukita T, Hirata M, Jimi E, Koga T. Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures. Endocrinology. 1994;134:1121-1126.
29. Hattersley G, Kerby JA, Chambers TJ. Identification of osteoclast precursors in multilineage hemopoietic colonies. Endocrinology. 1991;128:259-262.
30. Menaa C, Kurihara N, Roodman GD. CFU-GM-derived cells form osteoclasts at a very high efficiency. Biochem Biophys Res Comm. 2000;267:943-946.
31. Niida S, Kaku M, Amano H, et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med. 1999;190:293-298.
32. Lyman SD. c-kit Ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood. 1998;91:1101-1134.
33. Shurin MR, Esche C, Lotze MT. FLT3: receptor and ligand: biology and potential clinical application. Cytokine Growth Factor Rev. 1998;9:37-48.
34. Hattersley G, Owens J, Flanagan AM, Chambers TJ. Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro. Biochem Biophys Res Comm. 1991;177:526-531.
35. Chambers TJ, McSheehy PMJ, Thomson BM, Fuller K. The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology. 1985;116:234-239.
36. Burstone MS. Histochemical demonstration of acid phosphatases with naphthol AS-phosphate. J Natl Cancer Inst. 1958;21:423-539.
37. Chow J, Tobias JH, Colston KW, Chambers TJ. Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest. 1992;89:74-78.
38. Fuller K, Chambers TJ. Bone matrix stimulates osteoclastic differentiation in cultures of rabbit bone marrow cells. J Bone Miner Res. 1989;4:179-183.
39. Prallet B, Male P, Neff L, Baron R. Identification of a functional mononuclear precursor of the osteoclast in chicken medullary bone-marrow cultures. J Bone Miner Res. 1992;7:405-414.
40. Domon T, Osanai M, Yasuda M, et al. Mononuclear odontoclast participation in tooth resorption: the distribution of nuclei in human odontoclasts. Anat Rec. 1997;249:449-457.
41. Wiktor-Jedrzejczak W, Ahmed A, Szczylik C, Skelly RR. Hematological characterization of congenital osteopetrosis in op/op mouse. J Exp Med. 1982;156:1516-1527.
42. Fuller K, Owens JM, Jagger CJ, et al. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med. 1993;178:1733-1744.
43. Miyamoto T, Arai E, Ohneda O, Suda T. Identification and modulation of common progenitors of osteoclasts and dendritic cells [abstract]. J Bone Miner Res. 2000;15(suppl 1):S219.
44. Solanilla A, Grosset C, Lemercier C, et al. Expression of Flt3-ligand by the endothelial cell. Leukemia. 2000;14:153-162.
45. Gerber H-P, Vu TH, Ryan AM, et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999;5:623-628.
46. Lagasse E, Weissman IL. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell. 1997;89:1021-1031.
47. Rasko JEJ, Metcalf D, Rossner MT, Begley CG, Nicola NA. The flt3/flk-2 ligand: receptor distribution and action on murine hemopoietic cell survival and proliferation. Leukemia. 1995;9:2058-2066.
48. Papayannopoulou T, Nakamoto B, Andrews RG, Lyman SD, Lee MY. In vivo effects of Flt3/Flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with granulocyte colony-stimulating factor. Blood. 1997;90:620-629.
49. Hughes AE, Ralston SH, Marken J, et al. Signal peptide mutations in RANK cause familial expansile osteolysis. Nat Genet. 2000;24:45-49.
50. Chambers TJ. Regulation of the differentiation and function of osteoclasts. J Pathol. 2000;192:4-13.
51. Nicholls SE, Winter S, Mottram R, Miyan JA, Whetton AD. Flt3 ligand can promote survival and macrophage development without proliferation in myeloid progenitor cells. Exp Hematol. 1999;27:663-672.
52. Mackarehtschian K, Hardin JD, Moore KA, et al. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity. 1995;3:147-161.
53. McKenna HJ, Stocking KL, Miller RE, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood. 2000;95:3489-3497.
54. Maraskovsky E, Brasel K, Teepe M, et al. Dramatic increase in the numbers of functionally mature dendritic cells in flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med. 1996;184:1953-1962.
55. Halenbeck R, Kawasaki E, Wrin J, Koths K. Renaturation and purification of biologically active recombinant human macrophage colony-stimulating factor expressed in E. coli. Bio/Technology. 1989;7:710-715.